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Pakshaghata is one among the 80 Vataja Nanatmaja 
Vikara and is a Roga of Madhyama Roga Marga.
[1]
 
Vatavyadhi is considered to be one among the Ashta 
Mahagadas.
[2]
 The etiopathogenesis of Pakshaghata 
is explained in classics
[3]
 in which the vitiated Vata 
resides  in  one half of body and causes Vishoshana  of 
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Sira and Snayu  leading to loosening of joints leading 
to symptoms like Cheshta Nivrutti, Ruja and 
Vakstambha.
[4]




Cerebrovascular Accident (CVA) is not a disease in 
itself but is heterogeneous group of disorders. 
Hemiplegia is one of the most frequent and 
commonest clinical presentations of CVA.
[6]
 The World 
Health Organization (WHO) defines CVA as “the 
rapidly developing clinical symptoms and/or signs of 
focal disturbance of cerebral function, with symptoms 
lasting more than 24 hours or leading to death with 
no apparent cause other than that of vascular origin.
[7]
  
There are many risk factors for CVA including 
hypertension, diabetes, hyperlipidemia etc. All these 
are very common in the present era in mid aged 
people mainly due to unhealthy food habits and 
sedentary life style.  
CVA is the second major cause of death worldwide. 
The world wide incidence has been quoted as 2/1000 
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population/annum; about 4/1000 in people aged 45-
84 years.
[8]
 The prevalence of stroke in India shows a 
huge variation of 147-922/100,000 across diverse 
community-based studies.
[9]
 Eighty five percentages 
of stroke cases are due to cerebral infarction and 
fifteen percentages due to cerebral hemorrhage and 
1.5 times more often in male than female.
[10]
 
According to the India stroke fact sheet updated in 
2012, the estimated age-adjusted prevalence rate for 
stroke ranges between 84/100,000 and 262/100,000 




The allopathic line of treatment for CVA is medical 
support, thrombolysis, antiplatelet agents, 
anticoagulation, neuroprotection and 
rehabilitation.
[12]
 Pakshaghata chikitsa explained by 
the classics mainly include Snehana, Swedana and 
Virechana.
[13]
 Detailed description of other line of 
treatment for Pakshaghata is also available such as 
Snehana, Swedana, Mrudu Virechana, Mastishkya, 
Salvana Upanaha and Basti.
[14]
 
Vatagajankusha Rasa is a combination of Vyosha, 
Bhasmas, Vatsanabha, Karkatasringi, Haritaki etc.
[15]
 
of which shunti, maricha, pippali works as deepana 
and ama pachana. Vatsanabha has the properties like 
vikasi, vyavayi, yogavahi; which makes it easy to 
digest along with all the drugs present in 
Vatagajankusha Rasa. It opens all the micro channels 
and easy to reach on cellular level. Haritaki, 
Agnimantha, Karkatashringi work as deepana, 
Vatanulomaka, kapha nissaraka, Vatashamaka. All 
bhasmas does agni deepana and work as balya, 
Rasayana, Vata pradhana tridosha shamaka.
[16]
 In this 
way the combination of these drugs acts in the 
management of Pakshaghata. 
OBJECTIVE 
To evaluate the efficacy of Vatagajankusha Rasa with 
Pippali Churna and Manjishta Kwatha as Anupana in 
the management of Pakshaghata (CVA due to infarct) 
MATERIALS AND METHODS 
Source of data: Patients who attended the out-
patient department of Kayachikitsa at Sri 
Dharmasthala Manjunatheswara College of Ayurveda 
and Hospital, Hassan. 
Method of collection of data 
32 patients (Table 1) were screened and selected 
based on the screening form prepared. Data was 
collected using specially prepared case report form. 
The demographic details of 30 enrolled patients of 
Pakshaghata such as age, gender, educational status 
etc are represented in table below (Table 1). 




Predominance No of Patients (%) 










Marital Status Married 29 (96.66%) 
Smoking Present 20 (66.66%) 
Alcoholism Present 20 (66.66%) 
The observations related to the disease details of the 
30 patients of Pakshaghata are represented in table 
below (Table 2) 
Table 2: Observations related to disease 
Cheshta nivrutti Present 30 (100%) 
Vakstambha Present 22 (73.33%) 
Ruk Present 28 (93.33%) 
K/C/O 
Hypertension 




Present 13 (43.33%) 
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Diagnostic Criteria 
An elaborate proforma incorporating all the points of 
history taking and physical examinations mentioned in 
Ayurveda texts as well as in modern sciences was 
prepared. In this, special provision was made for 
Jnanendriya and Karmendriya pareeksha along with 
central nervous system examination (Sensory, Motor, 
Cranial nerve and Autonomic dysfunctions). 
Inclusion Criteria  
 Pakshaghata (CVA due to infarct) after the acute 
stage  
 Caused by most prevalent disease like Diabetes 
Mellitus, Hypertension, Hyperlipidemia (Any of 
these or all of these)  
 GCS more than 8  
 Either gender  
 Patients aged between 30-75 years  
 Those who are ready to sign the informed/oral 
consent form  
Exclusion Criteria  
 Pakshaghata complicated with heart disease, 
uncontrolled diabetes  
 Systemic disorders like CHD,CRF,CLD  
 History of HIV,HBSAG, Carcinoma  
 Pregnant women and lactating mother  
 H/O Intra cranial infection- encephalitis, 
meningitis  
 Cerebral tumor, cerebral abscess  
 Congenital defects- diffused sclerosis, cerebral 
agenesis  
 Marked impaired mental function  
Ethics 
Ethics clearance was obtained from Institutional 
Ethics Committee before initiation of the study (IEC 
No: SDM/IEC/16/2017-2018). 
Study design 
The study was open label, single arm, exploratory, 
prospective clinical on 30 patients of Pakshaghata 
selected using the convenience/ purposive (non-
random) sampling technique with pre and post test 
design conducted in a tertiary Ayurveda hospital 
attached to quarters in southern India. 
Intervention 
Medicines - Vatagajankusha Rasa with Pippali churna 
and Manjishta kwatha as anupana
 
Source and authentification of drug:  
 Vatagajankusha Rasa (125mg each) tablets were 
purchased from VIRGO Pharmacy, Gujarat, which 
is a GMP certified pharmacy.  
 Powdered Pippali was purchased from Sri 
Dharmasthala Manjunatheswara College of 
Ayurveda and Hospital pharmacy, Udupi, which is 
a GMP certified pharmacy.  
 Raw drugs for Manjishta kwatha were procured 
from Kajrekar pharmacy, Belagavi and were 
authenticated at Dravyaguna department of Sri 
Dharmasthala Manjunatheswara College of 
Ayurveda and Hospital, Hassan.  
Method of preparation of Manjishta Kwatha 
Roots of Manjishta were cleaned and dried. They 
were coarsely powdered, weighed as per formula and 
then mixed well. 4 parts of water added to 1 part of 
Manjishta coarse powder, boiled and reduced to 
1/4th part. Prepared kwatha was packed in 210 ml 
bottles and labeled with name of the drug, reference, 
details of the manufacturer, batch number. 
Treatment plan 
Vatagajankusha Rasa tablet of 125 mg after food with 
3 gm Pippali churna and 15ml Manjishta kwatha as 
anupana twice daily. 
Duration: 7 days 
Assessment criteria  
Primary outcome measures 
Assessment was done based on the improvement in 
the symptoms like Cheshta nivrutti, Vakstambha, Ruk 
after the administration of the medicine for 7 days 
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and also based on the improvement in the secondary 
outcome measures. 
Table 3: Cheshta Nivrutti grading 
Parameter Grading Observation 
Cheshta 
Nivrutti 
1 Normal  
2 Needs minor help 
3 Needs major help 
4 Complete loss of function  
Table 4: Vakstambha grading 
Parameter Grading Observation 
Vakstambha 1 Able to pronounce compound word 
2 Able to pronounce simple word but 
unable to pronounce compound word 
3 Slurred speech  
4 Aphasia  
Table 5: Ruk grading 
Parameter Grading Observation 
Ruk  1 No pain 
2 Mild pain occasionally  
3 Moderate tolerable pain 
4 Severe intolerable pain 
Secondary outcome measures:  
National Institute of Health Stroke Scale (NIHSS) 
OBSERVATIONS AND RESULTS 
In the present study, among the 40 patients screened, 
32 patients were registered of which 30 have 
completed their course of treatment. 
The effect of therapy in 30 patients of Pakshaghata is 
shown in the table below: 
Wilcoxon Signed Rank test was applied to note the 
significant changes in primary outcome measures with 
significant level at P value < 0.05 (Table 6). 
Table 6: Effect of therapy on primary outcome 
measures  
In 30 enrolled subjects, impairments were observed in 
the NIH Stroke Scale parameters like motor arm drift, 
motor leg drift and dysarthria. All other parameters of 
NIH Stroke Scale were found to be normal in the 
subjects. 
Wilcoxon Signed Rank test was applied to note the 
significant changes in NIH Stroke Scale parameters 
with significant level at P value < 0.05 (Table 7). 
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MR = Mean Rank, SR = Sum of Ranks, S= Significant, NS = Non 
Significant 
DISCUSSION 
Statistically significant improvements were observed 
in the primary and secondary outcome measures with 
administration of Vatagajankusha Rasa with Pippali 
churna and Manjishta kwatha as anupana. 
Assessment of these parameters was done after 7 
days of treatment. 
Statistically significant improvement was noticed in 
cheshta nivrutti after treatment. Wilcoxon signed rank 
test (P value=0.000) showed improvements in mean 
after treatment. 
Cheshta nivrutti is manifested due to the vyana Vata 
prakopa. Vatsanabha, Pippali, Manjishta, Haratala 
pacify Prakupita Vyana Vata by Snigdha Guna, Ushna 
Virya and Madhura Vipaka. Haritaki which is Laghu, 
Ushna, Madhura and Tridoshahara does the Vata 
anulomana. Oushadha sevana kala advised for vyana 




Another cause for Cheshta Nivrutti is the Shoshana of 
Sira and Snayu  by Ruksha-Teekshna Ahara Sevana, 
Dhatukshaya. These are the upadhatus of 
Raktadhatu. Manjishta and loha bhasma are rakta 
pRasadaka which nourishes the rakta and its 
upadhatus by tikta-madhura Rasa, madhura vipaka 
and guru guna.  
Statistically significant improvement was noticed in 
vakstambha after treatment. Wilcoxon signed rank 
test (P value=.001) showed improvements in mean 
after treatment. 
Samana avruta prana causes gadgada vakya and 
mookatva. Kaphavruta udana causes vak graha. Agni 
sameepastha samana Vata is pacified by agnideepana 
drugs such as pippali, shunti, tankana, agnimantha etc 
having katu Rasa, katu vipaka and ushna virya. 
Vatsanabha has vyavayi, vikasi and yogavahi 
properties by which it does kapha nisarana and clears 
Margavarana. Manjishta is “swara krut”, it improves 
the speech.  
Oushadha sevana kala advised for udana Vata is after 




Statistically significant improvement was noticed in 
Ruk after treatment. Wilcoxon signed rank test (P 
value=0.000) showed improvements in mean after 
treatment. 
Ruk is caused by Vata dosha due to laghu guna, 
darunata, ashukaritwa. Loha bhasma and Manjishta 
does Vata shamana by guru guna, madhura Rasa and 
ushna veerya.  
Haritaki is Vatanulomaka and brings Vata in its 
normal path thereby reduces ruk. Pippali and shunti 
are included in shoola prashamana dashemani due its 
ushna veerya and snigdha guna. Vatsanabha is 
rujapaha due to its vyavayi, vikasi and yogavahi 
properties thus relives ruk. 
Probable mode of action of Vatagajankusha Rasa 
According to Rasa Ratna Samuchhaya, after marana, 
bhasma becomes microfine particles that easily 
absorb into the body along with Rasa dhatu. Such 
absorbed bhasmas provide nourishment to the body 
and cures all types of diseases.
[19] 
Absorption into gut 
After marana the particle size of the bhasma reduces 
into the size of “platelets” (1.5 чm) and it can be 
absorbed through the gap junctions and epithelial 
tissues in middle gut. 
Entry to the blood stream 
Particles penetrate the intestinal barrier either by 
endocytosis, phagocytosis or persorption and transit 
to the blood stream. 
Crossing blood-brain barrier 
When a particle penetrates into the blood stream, 
perhaps tagged by and adjuvant with yogavahi 
properties, it reaches the specific target area. 
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Microfine particles with increased bio availability, 
cross the blood-brain barrier and act as neuro-
protectants.
[20] 
Mode of action of different ingredients 
 The combination of Rasa oushadhis act as kapha-
Vata pradhana tridosha hara. They increase the 
jataragni and works as balya and Rasayana 
 Shunti, maricha, pippali work as deepana, 
pachana. It improves digestion thereby improves 
the overall nourishment of the body 
 Vatsanabha has vikasi, vyavayi and yogavahi guna 
which make it easy to be digested. It opens all the 
micro channels and reaches cellular level 
 Karkatasringi, haritaki and agnimantha work as 
agni deepaka, Vatanulomaka, kapha nisaraka and 
Vata shamaka 
 Pippali is kapha-Vata hara and urdhwa bhaga 
hara dravya due to which it can improve the brain 
functions. It is of madhura vipaka and ushna 
veerya which counteracts Vata dosha. It is 
Rasayana. 
 Manjishta is pitta-kapha shamaka due to which it 
can counteract the pitta or kapha anubandha 
with Vata. It is rakta pRasadaka which improve 
the blood circulation. It is swara krut. 
CONCLUSION 
Administration of Vatagajankusha Rasa with Pippali 
churna and Manjishta kwatha as anupana for 7 days 
shown statistically significant improvement in the 
clinical features of Pakshaghata namely – cheshta 
nivrutti, vakstambha and ruk. Statistically significant 
improvement was observed in the NIH Stroke Scale 
parameters like motor arm drift and motor leg drift. 
There was no statistically significant improvement in 
dysarthria. The study showed more improvement in 
“ruk” followed by “cheshta nivrutti” and then 
“vakstambha”. Hence administration of 
Vatagajankusha Rasa (125 mg) twice daily with 
Pippali churna (3 gm) and Manjishta kwatha (15 ml) 
as anupana after food for 7 days is effective in the 
management of Pakshaghata (CVA due to infarct). 
REFERENCES 
1. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Sutra Sthana 20/11. 
Reprint ed. Varanasi (India): Chaukambha Orientalia; 
2014.p.113 
2. Acharya Y T. Sushruta Samhita with Nibandhasangraha 
commentary of Dalhanacharya. Sutra Sthana 33/3. 
Reprint ed. Varanasi (India): Chaukambha Sanskrit 
Sansthan; 2014. p. 144. 
3. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Chikitsa Sthana 
28/43. Reprint ed. Varanasi (India): Chaukambha 
Orientalia; 2014.p.619 
4. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Chikitsa Sthana 
28/44. Reprint ed. Varanasi (India): Chaukambha 
Orientalia; 2014.p.619 
5. Acharya Madhavakara, Madhava nidanam with 
madhukosha Sanskrit commentary by Acharya Vijaya 
Rakshit and Shrikanta Datt,Edited by Dr.Ravidatt 
Tripady,1st Volume 22th chapter, 1st Edition – 1993 
published by Varanaseya Sanskrit Sansthan, Page 
no.505 
6. John maclod edited Devid sons principles and practice 
of medecine edited 2003, pub:pitman press ,Great 
Britain. pp432 th.. 
7. Warlow CP, Dennis MS, VanGinj J et al : A practical 
approach to management of stroke patients. In : 
Stroke: a practical guide to management. Blackwell 
sciences, London. 1996; 360-384 
8. PRasad K, Vibha D, Meenakshi Cerebrovascular disease 
in South Asia - Part I: A burning problem. JRSM 
Cardiovasc Dis. 2012; 1:20. [PMC free article] [PubMed] 
9. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, 
Schoenberg BS. Prevalence of stroke in the Parsi 
community of Bombay. Stroke. 1988;19:60– 62. 
[PubMed] 
10. Colledge NickR, Walker BrainR, Ralston 
StuartH.Devidson,Principle and practice of 
medicine.reprint2010, pub:pitman press, Great Britain. 
P.1184 
11. Stroke fact sheet India. Accessed 21 July 2013. 
http://www.sancd.org/Updated%20Stroke%20Fact%20
sheet%202012.pdf) 
Yadu Gopan et al. An open label single arm prospective clinical study on Pakshaghata (CVA due to Infarct) 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Nov-Dec 2019 
 
Journal of Ayurveda and Integrated Medical Sciences | Nov - Dec  2019 | Vol. 4 | Issue 6 25 
 








edition. New York: McGraw Hill Education, 2015. 
P.2560 
13. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Chikitsa Sthana 
28/100. Reprint ed. Varanasi (India): Chaukambha 
Orientalia; 2014.p.621. 
14. Acharya Y T. Sushruta Samhita with Nibandhasangraha 
commentary of Dalhanacharya. Chikitsa Sthana 5/19. 
Reprint ed. Varanasi (India): Chaukambha Sanskrit 
Sansthan; 2014. p. 427-428 
15. Ambikadatta Sastry K S. Bhaishajyaratnavali of Sri 
Govindadasa. Vatavyadhi adhikara shloka 116-120. 
Varanasi (India): Chaukambha Sanskrit Sansthan; 1998. 
p. 383 
16. C.B. Jha, B.Bhattacharya, K.K. Narang. Bhasmas as 
natural nanorobots: the biorelevant metal complex. J. 
Tradt Nat Med 2015; 1(1): 2-9 
17. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Chikitsa Sthana 
30/299. Reprint ed. Varanasi (India): Chaukambha 
Orientalia; 2014.p.646. 
18. Acharya YT. Charaka Samhita with Ayurveda Dipika 
commentary of Chakrapani Datta. Chikitsa Sthana 
30/299. Reprint ed. Varanasi (India): Chaukambha 
Orientalia; 2014.p.646. 
19. C.B. Jha, B.Bhattacharya, K.K. Narang. Bhasmas as 
natural nanorobots: the biorelevant metal complex. J. 






How to cite this article: Yadu Gopan, Totad Muttappa,  
Vasantha B., Kiran K. An open label single arm 
prospective clinical study on Vatagajankusha Rasa with 
Pippali Churna and Manjishta Kwatha as Anupana in 
Pakshaghata (CVA due to Infarct). J Ayurveda Integr 
Med Sci 2019;6:19-25. 
http://dx.doi.org/10.21760/jaims.4.6.4 
 
Source of Support: Nil, Conflict of Interest: None 
declared. 
Copyright © 2019 The Author(s); Published by Maharshi Charaka Ayurveda Organization, Vijayapur (Regd). This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
